116 related articles for article (PubMed ID: 2570598)
1. D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine.
Barone P; Palma V; Parashos SA; Marin C; Chase TN; Campanella G
Boll Soc Ital Biol Sper; 1989 Apr; 65(4):337-41. PubMed ID: 2570598
[TBL] [Abstract][Full Text] [Related]
2. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D1 receptor modulation of pilocarpine-induced convulsions.
Barone P; Parashos SA; Palma V; Marin C; Campanella G; Chase TN
Neuroscience; 1990; 34(1):209-17. PubMed ID: 2139189
[TBL] [Abstract][Full Text] [Related]
4. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant action of SCH 23390 in the striatum of the rat.
al-Tajir G; Starr MS
Eur J Pharmacol; 1990 Dec; 191(3):329-36. PubMed ID: 1982269
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-fos protein in the experimental epilepsy induced by pilocarpine.
Barone P; Morelli M; Cicarelli G; Cozzolino A; DeJoanna G; Campanella G; DiChiara G
Synapse; 1993 May; 14(1):1-9. PubMed ID: 8511714
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors.
Alam AM; Starr MS
Neuroscience; 1993 Mar; 53(2):425-31. PubMed ID: 8098511
[TBL] [Abstract][Full Text] [Related]
8. SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.
Spina L; Longoni R; Mulas A; Di Chiara G
Psychopharmacology (Berl); 1989; 98(4):567-8. PubMed ID: 2570436
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
Rosenzweig-Lipson S; Bergman J
J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
[TBL] [Abstract][Full Text] [Related]
10. D1 and D2 dopamine receptor interactions with pilocarpine-induced oral activity in rats.
Levin ED; Ellison GD; See RE; South D; Young E
Pharmacol Biochem Behav; 1989 Jul; 33(3):501-5. PubMed ID: 2573903
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
Imperato A; Tanda G; Frau R; Di Chiara G
J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
[TBL] [Abstract][Full Text] [Related]
12. Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.
Collins P; Broekkamp CL; Jenner P; Marsden CD
Psychopharmacology (Berl); 1991; 103(4):503-12. PubMed ID: 1676528
[TBL] [Abstract][Full Text] [Related]
13. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
Kelland MD; Freeman AS; Chiodo LA
Synapse; 1988; 2(4):416-23. PubMed ID: 2973142
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat.
al-Tajir G; Chandler CJ; Starr BS; Starr MS
Neuropharmacology; 1990 Jul; 29(7):657-61. PubMed ID: 1974713
[TBL] [Abstract][Full Text] [Related]
15. Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse.
Burke K; Chandler CJ; Starr BS; Starr MS
Pharmacol Biochem Behav; 1990 Aug; 36(4):729-33. PubMed ID: 1977176
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
Bijak M; Danek L; Smiałowski A
Pol J Pharmacol Pharm; 1988; 40(5):535-41. PubMed ID: 2908137
[TBL] [Abstract][Full Text] [Related]
17. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Sonsalla PK; Manzino L; Heikkila RE
J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
[TBL] [Abstract][Full Text] [Related]
18. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
Carlson JH; Bergstrom DA; Weick BG; Walters JR
Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic modulation of lithium/pilocarpine-induced status epilepticus in rats.
George B; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1997 Sep; 19(7):481-8. PubMed ID: 9413831
[TBL] [Abstract][Full Text] [Related]
20. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
Carlson JH; Bergstrom DA; Demo SD; Walters JR
Eur J Pharmacol; 1988 Aug; 152(3):289-300. PubMed ID: 2906003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
